Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
- Locations
-
- City Of Hope - Chicago /ID# 279814 Zion, Illinois, United States
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279853 Grand Rapids, Michigan, United States
- Texas Oncology - Northeast Texas /ID# 280417 Tyler, Texas, United States
- Virginia Cancer Specialists - Fairfax /ID# 280415 Fairfax, Virginia, United States
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07562152
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
- Locations
-
- City of Hope Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- Medical Oncology Hematology Consultants Newark, Delaware, United States
- Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
NCT07491445
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Honor Health Research Institute Scottsdale, Arizona, United States
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07349537
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Johns Hopkins Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- START Midwest Grand Rapids, Michigan, United States
NCT07621718
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Piedmont Healthcare Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California, Los Angeles Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of California, San Francisco San Francisco, California, United States
NCT07145450
- Conditions
- PDAC
- Locations
-
- Herlev and Gentofte University Hospital Copenhagen, Denmark
- Charité Universitätsmedizin Berlin Berlin, Germany
- Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany
- Universitaetsklinikum Heidelberg Heidelberg, Germany
NCT06122896
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06922591
- Conditions
- Lung Cancer, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Sarah Cannon Research Institute Denver Denver, Colorado, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Mayo Clinic Jacksonville Jacksonville, Florida, United States
NCT06445062
- Conditions
- Adenocarcinoma, CRC, Carcinoma, +25 more
- Locations
-
- Ironwood Cancer and Research Centers Chandler, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- HonorHealth Research Institute Scottsdale, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
NCT06151223
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT07441174
- Conditions
- PDAC, Solid Tumor Cancer
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT07259590
- Conditions
- Advanced Solid Tumors Cancer, CRC (Colorectal Cancer), Colonic Diseases, +11 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06515587
- Conditions
- PDAC
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
The Canopy Cancer Collective Clinical Registry Protocol
NCT07605702
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
- Locations
-
- UC San Diego Health San Diego, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Not Yet Recruiting
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
NCT07198321
- Conditions
- CRC (Colorectal Cancer), Cancer, Colonic Diseases, +12 more
- Locations
-
- Sun-Yat sen university cancer center Guangzhou, Guangdong, China
Not Yet Recruiting
Mesopancreas Study in Pancreatic Cancer
NCT05895214
- Conditions
- Local Recurrent Tumor, Margin, Resection, Margins of Excision, +5 more
- Locations
-
- University Hospital Duesseldorf, Heinrich Heine University Düsseldorf, Germany
Active, Not Recruiting
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
NCT05355298
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- GenesisCare St Leonards, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- Gallipolli Medical Research Foundation Greenslopes, Queensland, Australia
Active, Not Recruiting
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06625320
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Cancer Center - Phoenix Phoenix, Arizona, United States
- City of Hope-Duarte Duarte, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
Active, Not Recruiting
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05642962
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States